Publications
CIBMTR Publication List
Since 1972, using CIBMTR data and statistical resources has resulted in more than 1,800 publications.
CIBMTR also makes its publication analysis datasets freely available to the public for secondary analysis while safeguarding participants' privacy and protecting confidential and proprietary data.
Browse Publications
2025 | Transplantation and Cellular Therapy
Donor type does not impact late graft failure following reduced-intensity allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis.
Authors:
Hickey CL, Zhang M, Allbee-Johnson M, Romee R, Majhail NS, Malki M, Antin JH, Benjamin CL, Bredeson C, Chhabra S, Grunwald MR, Inamoto Y, Kanakry CG, Milano F, Soiffer RJ, Spellman SR, Solomon SR, Brunstein CG, Cutler C
2022 | Blood Advances
HLA-matching with PTCy: A reanalysis of a CIBMTR dataset with propensity score matching and donor age.
Authors:
Ambinder A, Jain T, Tsai HL, Horowitz MM, Jones RJ, Varadhan R
2021 | Transplantation and Cellular Therapy
Umbilical cord blood or HLA-haploidentical transplantation: Real-world outcomes versus randomized trial outcomes.
Authors:
O'Donnell PV, Brunstein CG, Fuchs EJ, Zhang M-J, Allbee-Johnson M, Antin JH, Leifer ES, Elmariah H, Grunwald MR, Hashmi H, Horowitz MM, Magenau JM, Majhail N, Milano F, Morris LE, Rezvani AR, McGuirk JP, Jones RJ, Eapen M
2021 | Transplantation and Cellular Therapy
Planned granulocyte colony-stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy.
Authors:
Orfali N, Zhang M-J, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M
2021 | Blood Advances
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.
Authors:
Wagner JE, Ballen KK, Zhang M-J, Allbee-Johnson M, Karanes C, Milano F, Verneris MR, Eapen M, Brunstein CG
Authors:
Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M
2021 | Blood Advances
Alternative donor transplantation for myelodysplastic syndromes: Haploidentical relative and matched unrelated donors.
Authors:
Grunwald MR, Zhang M-J, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf DJ, Eapen M
2020 | Biology of Blood and Marrow Transplanta...
The effect of granulocyte colony-stimulating factor use on hospital length of stay after allogeneic hematopoietic cell transplantation: A retrospective multicenter cohort study.
Authors:
George G, Martin AS, Chhabra S, Eapen M
2020 | Biology of Blood and Marrow Transplanta...
Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant.
Authors:
Solomon SR, St Martin A, Zhang M-J, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M
2020 | Biology of Blood and Marrow Transplanta...
Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia.
Authors:
Eapen M, Zhang M-J, Tang X-Y, Lee SJ, Fei M-W, Wang H-L, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM
2020 | Biology of Blood and Marrow Transplanta...
Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.
Authors:
Hamadani M, Zhang M-J, Tang X-Y, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM
2020 | Journal of Clinical Oncology
Nonmyeloablative alternative donor transplantation for Hodgkin and non-Hodgkin lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.
Authors:
Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales M-A, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang M-J, Gluckman E, Montoto S, Eapen M
2019 | Blood Advances
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Authors:
Solomon SR, St. Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang M-J, Eapen M
2019 | Haematologica
Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: Young HLA-matched unrelated or haploidentical donor?
Authors:
Perales M-A, Tomlinson B, Zhang M-J, St. Martin A, Beitinjaneh A, Gibson J, Hogan W, Kekre N, Lazarus H, Marks D, McGuirk J, Romee R, Solh M, Wagner JE, Weisdorf DJ, de Lima M, Eapen M
2018 | Biology of Blood and Marrow Transplanta...
Bone marrow versus peripheral blood from unrelated donors for children and adolescents with acute leukemia.
Authors:
Keesler DA, St. Martin A, Bonfim C, Seber A, Zhang M-J, Eapen M
2018 | Haematologica
Is a matched sibling the ideal donor for hematopoietic cell transplant?
Authors:
Eapen M
2018 | Blood Advances
Related donor transplants: Has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Authors:
Robinson TM, Fuchs EJ, Zhang M-J, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis J-H, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A
2018 | Biology of Blood and Marrow Transplanta...
Cohort-controlled comparison of umbilical cord blood transplantation using carlecortemcel-L, a single progenitor-enriched cord blood, to double cord blood unit transplantation.
Authors:
Stiff PJ, Montesinos P, Peled T, Landau E, Rosenheimer Goudsmid NR, Mandel J, Hasson N, Olesinski E, Glukhman E, Snyder DA, Galamidi Cohen EG, Srur Kidron OS, Bracha D, Harati D, Ben-Abu K, Freind E, Freedman LS, Cohen YC, Olmer L, Barishev R, Rocha V, Gluckman E, Horowitz MM, Eapen M, Nagler A, Sanz G
2018 | Blood Advances
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
Authors:
McCurdy SR, Zhang M-J, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales M-A, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M
2017 | Journal of Clinical Oncology
Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donortransplantation using post-transplant cyclophosphamide.
Authors:
Bashey A, Zhang M-J, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales M-A, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M